Treatment of hypertension in pregnant women

New England Journal of Medicine

Volumn 335, Issue 4, 1996, Pages 257-265

  Sibai, Baha M ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METHYLDOPA;

ANTIHYPERTENSIVE THERAPY; CONVULSION; FETUS DEATH; HYPERTENSION; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; SODIUM RESTRICTION; SOLUTIO PLACENTAE; SYSTEMIC VASCULAR RESISTANCE;

ANTICONVULSANTS; ANTIHYPERTENSIVE AGENTS; BED REST; CHRONIC DISEASE; FEMALE; HUMANS; HYPERTENSION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 0029893242     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199607253350407     Document Type: Review

References (93)

1. National High Blood Pressure Education Program Working Group report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990;163: 1691-712.
2. Hughes EC, ed. Obstetric-gynecologic terminology with section on neonatology and glossary of congenital anomalics. Philadelphia: F.A. Davis, 1972.
3. Management of preeclampsia. Technical bulletin no. 91. Washington, D.C.: American College of Obstetricians and Gynecologists, 1986.
4. Roberts JM, Redman CWG. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993;341:1447-51. [Erratum, Lancet 1993; 342:504.]
5. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988;158:892-8.
6. Redman CWG, Jefferies M. Revised definition of pre-eclampsia. Lancet 1988;1:809-12.
7. Zuspan FP. New concepts in the understanding of hypertensive diseases during pregnancy: an overview. Clin Perinatol 1991;18:653-9.
8. Sibai BM. Diagnosis and management of chronic hypertension in pregnancy. Obstet Gynecol 1991;78:451-61.
9. Sibai BM, AkI S, Fairlie F, Moretti M. A protocol for managing severe preeclampsia in the second trimester. Am J Obstet Gynecol 1990;163:733-8.
10. Ales KL, Charlson ME. The prediction of adverse outcomes in antepartum hypertension. Clin Exp Hypertens [B] 1989;8:95-112.
11. Sibai BM, Abdella TN, Anderson GD. Pregnancy outcome in 211 patients with mild chronic hypertension. Obstet Gynecol 1983;61:571-6.
12. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (INC V). Arch Intern Med 1993;153:154-83.
13. Sibai BM, Anderson GD. Pregnancy outcome of intensive therapy in severe hypertension in first trimester. Obstet Gynecol 1986;67:517-22.
14. Chesley LC, Annitto JE. Pregnancy in the patient with hypertensive disease. Am J Obstet Gynecol 1947;53:372-81.
15. Landesman R, Holze W, Scherr L. Fetal mortality in essential hypertension. Obstet Gynecol 1955;6:354-65.
16. Sibai BM, Villar MA, Mabie BC. Acute renal failure in hypertensive disorders of pregnancy: pregnancy outcome and remote prognosis in thirty-one consecutive cases. Am J Obstet Gynecol 1990;162:777-83.
17. Kincaid-Smith P, Bullen M, Mills J. Prolonged use of methyldopa in severe hypertension in pregnancy. BMJ 1966;1:274-6.
18. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335:827-38.
19. Redman CWG. Controlled trials of antihypertensive drugs in pregnancy. Am J Kidney Dis 1991;17:149-53.
20. Leather HM, Humphreys DM, Baker PB, Chadd MA. A controlled trial of hypotensive agents in hypertension in pregnancy. Lancet 1968;2: 488-90.
21. Redman CWG. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet 1976;2:753-6.
22. Arias F, Zamora J. Antihypertensive treatment and pregnancy outcome in patients with mild chronic hypertension. Obstet Gynecol 1979;53:489-94.
23. Sihai BM, Grossman RA, Grossman HG. Effects of diuretics on plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynecol 1984;150:831-5.
24. Weitz C, Khouzami V, Maxwell K, Johnson JWC. Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study, Int J Gynaecol Obstet 1987;25:35-40.
25. Butters I., Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. BMJ 1990;301:587-9.
26. Sibai BM, Mabic WC, Shamsa F, Villar MA, Anderson GD. A comparison of no medication versus methyldopa or labctalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 1990;162:960-7.
27. Fidler J, Smith V, Fayers P, de Swiet M. Randomized controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy. BMJ 1983;286:1927-30.
28. Gallery EDM, Ross MR, Gyory AZ. Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa. BMJ 1985;291:563-6.
29. Horvath JS, Phippard A, Korda A, Henderson-Smart DJ, Child A, Tiller DJ. Clonidine hydrochloride - a safe and effective antihypertensive agent in pregnancy. Obstet Gynecol 1986;66:634-8.
30. Rosenfeld J, Bott-Kanner G, Boner G, et al. Treatment of hypertension during pregnancy with hydralazine monotherapy or with combined therapy with hydralazine and pindolol. Eur J Obstet Gynecol Reprod Biol 1986;22:197-204.
31. Plouin PF, Breart G, Llado J, et al. A randomised comparison of early with conservative use of antihypertensive drugs in the management of pregnancy-induced hypertension. Br J Obstet Gynaecol 1990;97:134-41.
32. Plouin PF, Breart G, Maillard F, Papiernik E, Relier JP. Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial. Br J Obstet Gynaecol 1988;95:868-76.
33. Blake S, MacDonald D. The prevention of the maternal manifestations of pre-eclampsia by intensive antihypertensive treatment. Br J Obstet Gynaecol 1991;98:244-8.
34. Cruickshank DJ, Campbell D, Robertson AA, MacGillivray I. Intrauterine growth retardation and maternal labetalol treatment in a random allocation controlled study. J Obstet Gynaecol 1992;12:223-7.
35. Cruickshank DJ, Robertson AA, Campbell DM, MacGillivray I. Maternal obstetric outcome measures in a randomized controlled study of labetalol in the treatment of hypertension in pregnancy. Clin Exp Hypertens [B] 1991;10:333-44.
36. Jannet D, Carbonrie B, Sebban E, Milliez J. Nicardipine versus metoprolol in the treatment of hypertension during pregnancy: a randomized comparative trial. Obstet Gynecol 1994;84:354-9.
37. Schoenfeld A, Segal J, Friedman S, Hirsch M, Ovadia J. Adverse reactions to antihypertensive drugs in pregnancy. Obstet Gynecol Surv 1986; 41:67-73.
38. Montan S, Anandakumar C, Arulkumaran S, Ingemarsson I, Ratnam SS. Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancy-induced hypertension. Am J Obstet Gynecol 1993;168:152-6.
39. Cockburn J, Moar VA, Ounsted M, Redman CW. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1982;1:647-9.
40. Montan S, Ingermarsson I, Marsal K, Sjoberg NO. Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics. BMJ 1992;304:946-9.
41. Collins R, Yusuf S, Peto R. Overview of randomised trials of diuretics in pregnancy. BMJ 1985;290:17-23.
42. Rosa FW, Bosco LA, Graham CF, Milstien JB, Dreis M, Creamer J. Neonatal anuria with maternal angiotensin-converting enzyme inhibition. Obstet Gynecol 1989;74:371-4.
43. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993;169:1000-6.
44. Sibai BM. Eclampsia. VI. Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 1990;163:1049-54.
45. Gilstrap LC III, Cunningham FG, Whalley PE. Management of pregnancy-induced hypertension in the nulliparous patient remote from term. Semin Perinatol 1978;2:73-81.
46. Sibai BM, Gonzalez AR, Mabie WC, Moretti M. A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term. Obstet Gynecol 1987;70:323-7.
47. Sibai RM, Barton JR, AkI S, Sarinoglu C, Mercer BM. A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of preeclampsia remote from term. Am J Obstet Gynecol 1992;167:879-84.
48. Barton JR, Stanziano GJ, Sibai BM. Monitored outpatient management of mild gestational hypertension remote from term. Am J Obstet Gynecol 1994;170:765-9.
49. Lopez-Llera M. Main clinical types and subtypes of eclampsia. Am J Obstet Gynecol 1992;166:4-9.
50. Douglas KA, Redman CWG. Eclampsia in the United Kingdom. BMJ 1994;309:1395-400.
51. Woods JB, Blake FG, Perry KG Jr, Magann EF, Martin RW, Martin JN Jr. Ascites: a portent of cardiopulmonary complications in the preeclamptic patient with the syndrome of hemolysis, elevated liver enzymes, and low platelets. Obstet Gynecol 1992;80:87-91.
52. Odendaal HJ, Pattinson RC, du Toit R. Fetal and neonatal outcome in patients with severe pre-eclampsia before 34 weeks. S Afr Med J 1987; 71:555-8.
53. Odendaal H, Pattinson R, Bam R, Grove D, Kotze T. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial. Obstet Gynecol 1990; 76:1070-5.
54. Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynccol 1994;171:818-22.
55. Goldenberg RL, Cliver SP, Bronstein J, Cutter GR, Andrews WW, Mennemeyer ST. Bed rest in pregnancy. Obstet Gynecol 1994;84:131-6.
56. Mathews DD. A randomized controlled trial of bed rest and sedation or normal activity and non-sedation in the management of non-albuminuric hypertension in late pregnancy. Br J Obstet Gynaecol 1977;84:108-14.
57. Tuffnell DJ, Lilford RJ, Buchan PC, et al. Randomised controlled trial of day care for hypertension in pregnancy. Lancet 1992;339:224-7.
58. Crowther CA, Bouwmeester AM, Ashurst HM. Does admission to hospital for bed rest prevent disease progression or improve fetal outcome in pregnancy complicated by non-proteinuric hypertension? Br J Obstet Gynaecol 1992;99:13-7.
59. Rubin PC, Butters L, Clark DM, et al. Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet 1983;1:431-4.
60. Wichman K, Ryden G, Karlberg BE. A placebo controlled trial of metoprolol in the treatment of hypertension in pregnancy. Scand J Clin Lab Invest Suppl 1984;169:90-5.
61. Hogstedt S, Lindeberg S, Axelsson O, et al. A prospective controlled trial of metoprolol-hydralazine treatment in hypertension during pregnancy. Acta Obstet Gynecol Scand 1985;64:505-10.
62. Ellenbogen A, Jaschevatzky O, Davidson A, Anderman S, Grunstein S. Management of pregnancy-induced hypertension with pindolol - comparative study with methyldopa. Int J Gynaecol Obstet 1986;24:3-7.
63. Pickles CJ, Symonds EM, Pipkin FB. The fetal outcome in a randomised double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension. Br J Obstet Gynaecol 1989;96:38-43.
64. Pickles CJ, Pipkin FB, Symonds EM. A randomised placebo controlled trial of labetalol in the treatment of mild to moderate pregnancy induced hypertension. Br J Obstet Gynaecol 1992;99:964-8.
65. Phippard AF, Fischer WE, Horvath JS, et al. Early blood pressure control improves pregnancy outcome in primigravid women with mild hypertension. Med J Aust 1991;154:378-82.
66. Ismail AAA, Mcdhat I, Tawfic TAS, Kholeif A. Evaluation of calcium-antagonist (nifedipine) in the treatment of pre-eclampsia. Int J Gynaecol Obstet 1993;40:39-43.
67. Hypertensive disorders in pregnancy, In: Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC III. Williams obstetrics. 19th ed, Norwalk, Conn.: Appleton & Lange, 1993:763-817.
68. Schiff E, Friedman SA, Sibai BM. Conservative management of severe preeclampsia remote from term. Obstet Gynecol 1994;84:626-30.
69. Fenakel K, Fenakel G, Appelman Z, Lurie S, Katz Z, Shoham Z. Nifedipine in the treatment of severe preeclampsia. Obstet Gynecol 1991;77: 331-7
70. Mabie WC, Gonzalez AR, Sibai BM, Amon EA. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol 1987;70:328-33.
71. Paterson-Brown S, Robson SC, Redfern N, Walkinshaw SA, de Swiet M. Hydralazine boluses for the treatment of severe hypertension in preeclampsia. Br J Obstet Gynaecol 1994;101:409-13.
72. Garden A, Davey DA, Dommisse J. Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy. Clin Exp Hypertens [B] 1982;1:371-83.
73. Michael CA. Intravenous labetalol and intravenous diazoxide in severe hypertension complicating pregnancy. Aust N Z J Obstet Gynaecol 1986; 26:26-9.
74. Ashe RG, Moodley J, Richards AM, Philpott RH. Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy. S Afr Med J 1987;71:354-6.
75. Scabe SJ, Moodley J, Becker P. Nifedipine in acute hypertensive emergencies in pregnancy. S Afr Med J 1989;76:248-50.
76. Moodley J, Gouws E, A comparative study of the use of epoprostenol and dihydralazine in severe hypertension in pregnancy. Br J Obstet Gynaecol 1992;99:727-30.
77. Martins-Costa S, Ramos JG, Barros E, Brano RM, Costa CA, Goldin JR. Randomized, controlled trial of hydralazine versus nifedipine in preeclamptic women with acute hypertension, Clin Exp Hypertens [B] 1992; 11:25-44.
78. Rossouw HJ, Howarth G, Odendaal HJ. Ketanserin and hydralazine in hypertension in pregnancy - a randomised double-blind trial. S Afr Med J 1995;85:525-8.
79. Duggan PM, McCowan LME, Stewart AW. Antihypertensive drug effects on placental flow velocity waveforms in pregnant women with severe hypertension. Aust N Z J Obstet Gynaecol 1992;32:335-8.
80. Sibai BM, Ramanathan J. The case for magnesium sulfate in preeclampsia-eclampsia. Int J Obstet Anesth 1992;1:167-75.
81. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995;333:201-5.
82. Walker JJ. Hypertensive drugs in pregnancy: antihypertensive therapy in pregnancy, preeclampsia, and eclampsia. Clin Perinatol 1991;18:845-73.
83. Chua S, Redman CW. Are prophylactic anticonvulsants required in severe pre-eclampsia? Lancet 1991;337;250-1.
84. Moodley J, Moodley VV. Prophylactic anticonvulsant therapy in hypertensive crises of pregnancy - the need for a large, randomized trial. Hypertens Pregnancy 1994;13:245-52.
85. Burrows RF, Burrows EA. The feasibility of a control population for a randomized control trial of seizure prophylaxis in the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1995;173:929-35.
86. Duley L, Magnesium and eclampsia. Lancet 1995;346:1365.
87. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995;345:1455-63.
88. Steegers EA, Van Lakwijk HP, Jongsma HW, et al. (Patho)physiological implications of chronic dietary sodium restriction during pregnancy: a longitudinal prospective randomized study. Br J Obstet Gynaecol 1991;98: 980-7.
89. Dekker GA, Sibai BM. Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: rationale, mechanisms, and clinical trials. Am J Obstet Gynecol 1993;168:214-27.
90. Sibai BM, Caritis SN, Thom E, et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med 1993;329:1213-8.
91. CLASP (Collaborative Low-Dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994;343:619-29.
92. Belizan JM, Villar J. The relationship between calcium intake and edema-, proteinuria-, and hypertension-gestosis: an hypothesis. Am J Clin Nutr 1980;33:2202-10.
93. Carroli G, Duley L, Belizan JM, Villar J. Calcium supplementation during pregnancy: a systematic review of randomised controlled trials. Br J Obstet Gynaecol 1994;101:753-8.